Prevalence of steatotic liver disease, advanced fibrosis and cirrhosis among community-dwelling overweight and obese individuals in the USA

肝硬化 超重 医学 肥胖 内科学 体质指数 瞬态弹性成像 肝病 胃肠病学 脂肪肝 前瞻性队列研究 队列 疾病 肝纤维化
作者
Alexander H. Yang,Monica A. Tincopa,Federica Tavaglione,Veeral H. Ajmera,Lisa Richards,Maral Amangurbanova,Christian H. Butcher,Christie Hernandez,Egbert V. Madamba,Seema Singh,Ricki Bettencourt,Bernd Schnabl,Claude B. Sirlin,Rohit Seth Loomba
出处
期刊:Gut [BMJ]
卷期号:73 (12): 2045-2053 被引量:70
标识
DOI:10.1136/gutjnl-2024-332917
摘要

BACKGROUND: There are limited prospective data among overweight and obese individuals on the prevalence of advanced fibrosis, and cirrhosis using advanced MRI-based methods in the USA. The aim of this study was to fill that gap in knowledge by prospectively determining the MRI-based prevalence of steatotic liver disease (SLD) and its subcategories, advanced fibrosis and cirrhosis among overweight and obese individuals residing in the USA. METHODS: This is a cross-sectional analysis of prospectively enrolled overweight or obese adults aged 40-75 years from primary care and community-based settings in Southern California. Participants were classified as having SLD if MRI proton density fat fraction ≥5%, and subclassified as metabolic dysfunction-associated steatotic liver disease (MASLD), metabolic dysfunction and alcohol-associated liver disease (MetALD) and alcohol-related liver disease (ALD) consistently with the new nomenclature guidance per AASLD-EASL-ALEH. Advanced fibrosis and cirrhosis were defined as magnetic resonance elastography (MRE) ≥3.63 kPa and MRE ≥4.67 kPa, respectively. RESULTS: , respectively. The prevalence of SLD, advanced fibrosis and cirrhosis was 75%, 10.8% and 4.5%, respectively. The prevalence of MASLD, MetALD and ALD was 67.3%, 4.8% and 2.6%, respectively. There was no difference in prevalence of advanced fibrosis and cirrhosis among subcategories. CONCLUSIONS: Using advanced MRI methods among community-dwelling overweight and obese adults, the prevalence of cirrhosis was 4.5%. Most common SLD subcategory was MASLD with 67% of individuals, whereas MetALD and ALD were less common. Systematic screening for advanced fibrosis among overweight/obese adults may be considered.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
之和发布了新的文献求助20
1秒前
炒粉不要放鸡精啊完成签到,获得积分20
1秒前
机灵曼青完成签到 ,获得积分10
3秒前
lwroche发布了新的文献求助10
3秒前
3秒前
洋芋发布了新的文献求助10
3秒前
4秒前
4秒前
cyl发布了新的文献求助30
4秒前
haikuotian完成签到,获得积分0
4秒前
豆芽发布了新的文献求助10
5秒前
小西瓜发布了新的文献求助10
5秒前
Clarity发布了新的文献求助150
6秒前
Akim的应助被明亮翼采纳,获得10
6秒前
燕儿发布了新的文献求助10
7秒前
月夕花晨发布了新的文献求助10
7秒前
刘铭发布了新的文献求助10
7秒前
8秒前
科研通AI6.3的应助被江子川采纳,获得10
8秒前
8秒前
多半是只废兔子完成签到 ,获得积分10
8秒前
赘婿的应助被江子川采纳,获得10
9秒前
研友_VZG7GZ的应助被江子川采纳,获得10
9秒前
Jasper的应助被江子川采纳,获得10
9秒前
情怀的应助被江子川采纳,获得10
9秒前
Nole的应助被不能吃了采纳,获得10
10秒前
口农完成签到 ,获得积分10
10秒前
上官若男的应助被江子川采纳,获得10
11秒前
芸遥发布了新的文献求助10
11秒前
11秒前
Nole的应助被LeeNeaul采纳,获得10
11秒前
科研通AI6.3的应助被江子川采纳,获得10
11秒前
NexusExplorer的应助被江子川采纳,获得10
11秒前
科研通AI6.3的应助被江子川采纳,获得10
11秒前
打打的应助被江子川采纳,获得10
11秒前
ddk完成签到 ,获得积分10
12秒前
12秒前
乐乐的应助被不安晓曼采纳,获得10
13秒前
orixero的应助被yqhuang采纳,获得10
13秒前
Tiramisu_rainy完成签到,获得积分10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Agyptische Geschichte der 21.30. Dynastie 510
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8192519
求助须知:如何正确求助?哪些是违规求助? 9579028
关于积分的说明 21863207
捐赠科研通 7792025
什么是DOI,文献DOI怎么找? 3436955
关于科研通互助平台的介绍 2560622
邀请新用户注册赠送积分活动 2483832